$Hemispherx Biopharma(HEB)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2019-02-14 AccNo: 0001493152-19-002134 Size: 587 KB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-02-11 AccNo: 0001493152-19-001665 Size: 40 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-02-07 AccNo: 0001493152-19-001486 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-02-06 AccNo: 0001493152-19-001474 Size: 2 MB 网页链接
$Hemispherx Biopharma(HEB)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-04 AccNo: 0001535610-19-000031 Size: 15 KB 网页链接
$Hemispherx Biopharma(HEB)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-12-27 AccNo: 0001493152-18-018009 Size: 835 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 8-K - Current report Filed: 2018-12-11 AccNo: 0001493152-18-017324 Size: 46 KBItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 内部交易: 2018-11-30,Exec. 副Chairman/CEO/Pres.,EQUELS THOMAS K. ,买入,20000普通股, $0.19
$Hemispherx BioPharma, Inc.(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-14 AccNo: 0001493152-18-016149 Size: 5 MB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-14 AccNo: 0001493152-18-016149 Size: 5 MB 网页链接